ATH alterity therapeutics limited

Ann: Alterity Presents Encouraging New Phase 2 Data in MSA, page-43

  1. 3,279 Posts.
    lightbulb Created with Sketch. 298
    Data also definately opens the door for a direct phase 2 study trial in PD based on page 12, as evidence of reduced iron in the globus pallidus.
    Iron in the globus pallidus is a cause of parkinsons, than as mentioned by pivalde the significant reduction in brain atrophy likely increasing life expectancy...

    https://hotcopper.com.au/data/attachments/6942/6942462-74f0330cce4c186ddf1f25c8647506be.jpg
    https://hotcopper.com.au/data/attachments/6942/6942465-ec6cbe3c045a2c1b4a2a5a8a50a05cac.jpg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.1¢
Change
0.000(0.00%)
Mkt cap ! $100.4M
Open High Low Value Volume
1.0¢ 1.1¢ 1.0¢ $60.81K 5.737M

Buyers (Bids)

No. Vol. Price($)
37 16255465 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 1643984 2
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.